Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S. FDA is acknowledging that the drugs don’t have the same risk seen with older weight-loss ...
Super Greens supplement powder recalled after salmonella outbreak sickens dozens - The products were distributed nationwide, ...
The U.S. Food and Drug Administration on Wednesday said the outbreak was caused by the Live It Up-brand Super Greens dietary ...
A few recent examples of the FDA’s approach to drugs show how bad the agency’s risk aversion has become. The FDA has ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
Sen. Bill Cassidy criticized a policy instituted under President Joe Biden which has made Mifepristone available by mail.
Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
HHS has denied any nefarious intent behind the FDA’s removal of the page. In a statement to Ars Technica, a representative ...
The FDA told influenza vaccine makers they should add a warning about an increased febrile seizure risk in babies and ...
The FDA said it wants suicide warnings to be taken off some popular weight-loss medications following a comprehensive safety ...
The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.
The Modern Warrior dietary supplement Modern Warrior Ready, which claimed to improve brain function, boost metabolism, and ...